news

Global pharmaceutical filler market set to increase 5.7 percent

0
SHARES

The filler market is predicted to increase to US$2 billion by 2024, according to a new report.

The global pharmaceutical fillers market is predicted to increase at a compound annual growth rate (CAGR) of 5.7 percent in the forecast period 2019 to 2024.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Research and Markets, who conducted the analysis, project that the market will reach US$2 billion by the end of the forecast period.

The major drivers for this growth are listed as increased government spending on healthcare, disease prevalence and a growing demand for generic medicines.

Using lactose as a filler is highlighted as an emerging trend which has had a direct impact upon the global pharmaceutical filler industry. This is set to remain the largest segment because of its high compatibility with active pharmaceutical ingredients (APIs) and an increasing demand for antacid tablets.

Tablets are expected to remain as the largest application and this is set to experience the highest growth within the industry. The researchers suggest this will be due to increasing healthcare expenditure and higher incidence rates of chronic diseases.

North America is predicted to remain as the dominating market due to high healthcare expenditure and an aging population. However, the highest growth is expected from Asia Pacific because of increased government spending on healthcare infrastructure and rising health insurance policies.

Some of the major players in this market include Merck Group, Lactose India Limited and Omya.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Share via